[HTML][HTML] Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Bäcklund, E Palojoki, A Saraste, A Eriksson… - Diabetologia, 2004 - Springer
Aims/hypothesis Diabetes is known to reduce survival after myocardial infarction. Our aim
was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis …

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Bäcklund, E Palojoki, A Saraste, A Eriksson… - …, 2004 - search.proquest.com
Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in
experimental diabetes Page 1 Abstract Aims/hypothesis. Diabetes is known to reduce survival …

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Bcklund, E Palojoki, A Saraste, A Eriksson… - Diabetologia, 2004 - infona.pl
Aims/hypothesis. Diabetes is known to reduce survival after myocardial infarction. Our aim
was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis …

[PDF][PDF] Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Bäcklund, E Palojoki, A Saraste, A Eriksson… - Diabetologia, 2004 - researchgate.net
Aims/hypothesis. Diabetes is known to reduce survival after myocardial infarction. Our aim
was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis …

[引用][C] Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T BÄCKLUND, E PALOJOKI, I TIKKANEN… - Diabetologia …, 2004 - pascal-francis.inist.fr
Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial
infarction in experimental diabetes CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Bäcklund, E Palojoki, A Saraste… - …, 2004 - pubmed.ncbi.nlm.nih.gov
Aims/hypothesis Diabetes is known to reduce survival after myocardial infarction. Our aim
was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis …

[引用][C] Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Backlund, E Palojoki, A Saraste, A Eriksson… - …, 2004 - researchportal.helsinki.fi
Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial
infarction in experimental diabetes — University of Helsinki Skip to main navigation Skip to …

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.

T Bäcklund, E Palojoki, A Saraste, A Eriksson… - Diabetologia, 2004 - europepmc.org
Methods Four weeks after intravenous streptozotocin (diabetic groups) or citrate buffer
(controls) injection, myocardial infarction was produced by ligation of left descending …

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes T. Bäcklund et al.: Cardiomyocyte apoptosis …

T Bäcklund, E Palojoki, A Saraste, A Eriksson… - …, 2004 - search.ebscohost.com
Aims/hypothesis. Diabetes is known to reduce survival after myocardial infarction. Our aim
was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis …

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

T Bäcklund, E Palojoki, A Saraste, A Eriksson… - Diabetologia, 2004 - infona.pl
Aims/hypothesis Diabetes is known to reduce survival after myocardial infarction. Our aim
was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis …